Empirical Agent-Based Modelling for exploring Intergroup Contact in a Segregated Society

Agent-based modelling has a long history of application in the study of segregation, but is rarely deployed beyond the examination of residential segregation. This study leverages multiple datasets: including census, survey, PGIS and GPS traces; in order to create an empirical agent-based model for the exploration of mobility practices between segregated communities in Belfast (Northern Ireland). In doing so, we are able to conduct novel examinations into the impact of day-to-day mobility choices upon intergroup attitudes and activity-space segregation; with policy implications for understanding and combatting segregation in cities around the world

Emittance Reduction of RF Photoinjector Generated Electron Beams by Transverse Laser Beam Shaping

Laser pulse shaping is one of the key elements to generate low emittance electron beams with RF photoinjectors. Ultimately high performance can be achieved with ellipsoidal laser pulses, but 3-dimensional shaping is challenging. High beam quality can also be reached by simple transverse pulse shaping, which has demonstrated improved beam emittance compared to a transversely uniform laser in the 'pancake' photoemission regime. In this contribution we present the truncation of a Gaussian laser at a radius of approximately one sigma in the intermediate (electron bunch length directly after emission about the same as radius) photoemission regime with high acceleration gradients (up to 60 MV/m). This type of electron bunch is used e.g. at the European XFEL and FLASH free electron lasers at DESY, Hamburg site and is being investigated in detail at the Photoinjector Test facility at DESY in Zeuthen (PITZ). Here we present ray-tracing simulations and experimental data of a laser beamline upgrade enabling variable transverse truncation. Initial projected emittance measurements taken with help of this setup are shown, as well as supporting beam dynamics simulations. Additional simulations show the potential for substantial reduction of slice emittance at PITZ. © Published under licence by IOP Publishing Ltd

Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.

Effective public health measures against SARS-CoV-2 require granular knowledge of population-level immune responses. We developed a Tripartite Automated Blood Immunoassay (TRABI) to assess the IgG response against three SARS-CoV-2 proteins. We used TRABI for continuous seromonitoring of hospital patients and blood donors (n = 72'250) in the canton of Zurich from December 2019 to December 2020 (pre-vaccine period). We found that antibodies waned with a half-life of 75 days, whereas the cumulative incidence rose from 2.3% in June 2020 to 12.2% in mid-December 2020. A follow-up health survey indicated that about 10% of patients infected with wildtype SARS-CoV-2 sustained some symptoms at least twelve months post COVID-19. Crucially, we found no evidence of a difference in long-term complications between those whose infection was symptomatic and those with asymptomatic acute infection. The cohort of asymptomatic SARS-CoV-2-infected subjects represents a resource for the study of chronic and possibly unexpected sequelae

Highly-efficient broadband waveguide outcoupling in light-emitting diodes with self-organized polymer blends

10.1063/1.1801680Applied Physics Letters85142965-2967APPL

Matrix-assisted laser desorption-ionization imaging mass spectrometry for direct tissue analysis.

Matrix-assisted laser desorption-ionization (MALDI) imaging mass spectrometry (IMS) is a powerful tool in histopathological characterization and represents a modern analytical technique, enabling two-dimensional detection of molecular components of biological samples. Using this method, it is possible to investigate the spatial distribution of proteins, lipids, carbohydrates, cholesterols, nucleic acids, phospholipids, and small molecules in biological systems by in-situ analysis of cell cultures and tissue sections. Recently, MALDI-IMS has become an essential tool for tissue analyses in life science applications, offering global analysis of tissue samples. An advantage of this imaging technique is the acquisition of local molecular expression profiles up to the microscopic level, while maintaining the topographic integrity of the tissue by avoiding time-consuming extraction, purification, or separation steps, respectively. With MALDI-IMS it is possible to determine the distribution of hundreds of unknown compounds in a single measurement, allowing rapid probing of the tissues' biochemistry. Moreover, MALDI-IMS results include qualitative and semiquantitative information, providing unique chemi-morphological information about the tissue status, which represents an important benefit for future analytical interpretation of pathological changes of a tissue. This article summarizes the most recent advances in sample preparation, instrumentation, and data-processing techniques for MALDI-IMS

MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer.

[object Object]: New biomarkers are needed to improve the specificity of prostate cancer detection and characterisation of individual tumors. In a proteomics profiling approach using MALDI-MS tissue imaging on frozen tissue sections, we identified discriminating masses. Imaging analysis of cancer, non-malignant benign epithelium and stromal areas of 15 prostatectomy specimens in a test and 10 in a validation set identified characteristic m/z peaks for each tissue type, e.g. m/z 10775 for benign epithelial, m/z 6284 and m/z 6657.5 for cancer and m/z 4965 for stromal tissue. A 10-fold cross-validation analysis showed highest discriminatory ability to separate tissue types for m/z 6284 and m/z 6657.5, both overexpressed in cancer, and a multicomponent mass peak cluster at m/z 10775-10797.4 overexpressed in benign epithelial tissue. ROC AUC values for these three masses ranged from 0.85 to 0.95 in the discrimination of malignant and non-malignant tissue. To identify the underlying proteins, prostate whole tissue extract was separated by nano-HPLC and subjected to MALDI TOF/TOF analysis. Proteins in fractions containing discriminatory m/z masses were identified by MS/MS analysis and candidate marker proteins subsequently validated by immunohistochemistry (IHC). Biliverdin reductase B (BLVRB) turned out to be overexpressed in PCa tissue. BIOLOGICAL SIGNIFICANCE: In this study on cryosections of radical prostatectomies of prostate cancer patients, we performed a MALDI-MS tissue imaging analysis and a consecutive protein identification of significant m/z masses by nano-HPLC, MALDI TOF/TOF and MS/MS analysis. We identified BLVRB as a potential biomarker in the discrimination of PCa and benign tissue, also suggesting BVR as a feasible therapeutic target